ArticleDiabetology international2024

Efficacy and safety of switching from a dipeptidyl peptidase-4 inhibitor to oral semaglutide in Japanese patients with type 2 diabetes mellitus.

Chihiro Yoneda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.